<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CatsWannaBeCats.Com | Carlton Hopkins | Activity</title>
	<link>https://www.catswannabecats.com/members/fruitox82/activity/</link>
	<atom:link href="https://www.catswannabecats.com/members/fruitox82/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Carlton Hopkins.</description>
	<lastBuildDate>Thu, 25 Jun 2026 06:52:40 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=7.2.0</generator>
	<language>en-CA</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">2aa23ac70ffeaae563a90b2f00bd89c6</guid>
				<title>Carlton Hopkins posted an update: 2019 edition of National Health Interview Survey, we found [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/25179/</link>
				<pubDate>Sun, 08 Jun 2025 17:27:58 -0400</pubDate>

									<content:encoded><![CDATA[<p>2019 edition of National Health Interview Survey, we found that 50.2 million adults (20.5%) reported pain on most days or every day. The most common pain locations were back pain and hip, knee, or foot pain. The most commonly used management strategies for chronic pain were physical therapy and massage. Respondents with chronic pain reported&hellip;<span class="activity-read-more" id="activity-read-more-25179"><a href="https://www.catswannabecats.com/activity/p/25179/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">2fcd4bdde7817a9c025ff239dee28d1c</guid>
				<title>Carlton Hopkins posted an update: Intravitreal administration of ADVM-022 was well tolerated [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/23020/</link>
				<pubDate>Sat, 07 Jun 2025 17:42:59 -0400</pubDate>

									<content:encoded><![CDATA[<p>Intravitreal administration of ADVM-022 was well tolerated and resulted in sustained aflibercept levels in ocular tissues. In addition, ADVM-022 administration 13 months before laser-induced CNV prevented the occurrence of clinically relevant CNV lesions, to the same degree as a bolus of aflibercept delivered at the time of laser. These results&hellip;<span class="activity-read-more" id="activity-read-more-23020"><a href="https://www.catswannabecats.com/activity/p/23020/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">1097ebd041f14b4af6c5a504a827217c</guid>
				<title>Carlton Hopkins posted an update: Besides its contribution in the treatment of Human [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/19617/</link>
				<pubDate>Thu, 05 Jun 2025 08:21:38 -0400</pubDate>

									<content:encoded><![CDATA[<p>Besides its contribution in the treatment of Human Immunodeficiency Virus-infected patients, anti-retroviral drugs may also cause mild to serious adverse effects. It is the main causes for poor drug adherence, treatment discontinuation and changes in Anti-Retroviral Treatment (ART) regimens. Thus, the aim of this study was to assess the incidence&hellip;<span class="activity-read-more" id="activity-read-more-19617"><a href="https://www.catswannabecats.com/activity/p/19617/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">ab7337c2aa9ad411439d080f006dbf54</guid>
				<title>Carlton Hopkins posted an update: 8 months after transplantation (HR 1.55, P = 0.042), and [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/11803/</link>
				<pubDate>Sun, 01 Jun 2025 08:10:57 -0400</pubDate>

									<content:encoded><![CDATA[<p>8 months after transplantation (HR 1.55, P = 0.042), and this adverse effect was not detected any more after 10.8 months (HR 0.58, P = 0.107). Compared with early-EBVneg group after adjusting by aGVHD and CMV viremia, HR for death from transplant-related mortality was 2.78-fold higher in patients with early-EBV viremia in piecewise constant Cox&hellip;<span class="activity-read-more" id="activity-read-more-11803"><a href="https://www.catswannabecats.com/activity/p/11803/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">f285edf16cc19bd6c793fd98b4d20580</guid>
				<title>Carlton Hopkins posted an update: The polyoxometalates with designable size and redox property [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/2814/</link>
				<pubDate>Sat, 31 May 2025 09:19:36 -0400</pubDate>

									<content:encoded><![CDATA[<p>The polyoxometalates with designable size and redox property enable the flexible regulation of interaction between the nanotubes and the clusters, thus tuning the diameter of sorted s-SWCNTs. The present sorting strategy is simple and should be generally feasible in other SWCNT sorting techniques, bringing both great easiness in dispersant design&hellip;<span class="activity-read-more" id="activity-read-more-2814"><a href="https://www.catswannabecats.com/activity/p/2814/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">1abab31d69e6a5b5c656d6ae03e0d7c2</guid>
				<title>Carlton Hopkins became a registered member</title>
				<link>https://www.catswannabecats.com/activity/p/2715/</link>
				<pubDate>Sat, 31 May 2025 09:01:36 -0400</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>